Manager, Enterprise

**Job Title**
Manager - Enterprise, Biomedical Innovation (NHIC) (3-year Contract)

**About NHIC**
The National Health Innovation Centre Singapore (NHIC), is a nationally-appointed
Innovation and Enterprise Office that works with Public Health Institutions across Singapore
to identify and commercialise promising clinical innovations. We fund the translation and
development of medical innovations from Singapore’s clinical sector, and provide strategic
guidance and connection to industry partners, accelerating the pathway to impact in
healthcare. NHIC programmes catalyse the translation of clinical innovations towards
commercially viable products that benefit patients and healthcare. Established since 2014,
we have supported many projects and companies in the development and implementation
of innovative medical technologies and services, improving the standard of healthcare in
Singapore and beyond. NHIC is part of the Consortium for Clinical Research and Innovation
Singapore (CRIS).

Your key role would be to enhance the Enterprise function in marketing, communications and
go-to-market strategies for projects.

Your core function involves marketing and commercialisation of Intellectual Property (IP)
developed through NHIC support. This includes licensing support to the clinical institutions
such as valuation and negotiation of licensing deals, and market analyses of selected
technologies and IP in biotech/biomedical science. You will be expected to establish
partnerships with key stakeholders in the innovation, tech and venture community to
accelerate the go-to-market strategies for projects gearing towards spinning off and industry
commercialisation.

At the same time, day-to-day activities include project management, support and guidance to
clinician-led project teams funded by NHIC’s innovation development grants. You will support
and manage assigned biomedical projects and deliverables, coordinate and conduct project
reviews and evaluation panel meetings, review and evaluate project proposals and invention
disclosures. You will also work with various local government grant agencies and
incubators/accelerators to support the projects.

**Requirements
- Minimum Qualifications: Degree in Biomedical Sciences or Business

Administration/Marketing with exposure to biotech/medtech sectors.
- Minimum 3-5 years facilitating the translation and commercialisation of biomedical

fields would be suitable:
Restricted, Non-Sensitive

(1) Marketing and communications experience, including managing social media
engagement and events

(2) Product development in a biomedical science, pharma, biotech or medtech
company

(3) Project management or clinical development in a biomedical or clinical
institution/university

(4) Business Development role in a biomedical science, pharma, biotech or medtech
company, or research organisation, institution, hospital or university

(5) Relevant working experience in biotech/medtech start-up, venture capital, venture
builder, accelerator or corporate innovation unit.

venture capital, start-ups, corporates, international partners) for commercial purposes.
- Strong analytical ability with good problem solving and management skills. Proactive,

responsible and detail oriented, with the ability to identify and manage organisational
risks.
- Strong organisational, interpersonal, communication, and writing skills. Some

experience in PR/comms, marketing or events would be an advantage.
- Able to multi-task and work independently as well as part of cross-functional teams.

senior positions and career development opportunities. Designation and remuneration

Biomedical Innovation (NHIC)

**Company Overview**

The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly owned
subsidiary of MOH Holdings, was established in 2020 with the goal of strengthening
synergies and promulgating strategies for national-level clinical research and translation
programmes under the stewardship of the Singapore Ministry of Health. The former
Singapore Clinical Research Institute Pte Ltd was repurposed to form CRIS which brings
together five entities as business units under a common management and governance
structure. These are the Singapore Clinical Research Institute (SCRI), the National Health
Innovation Centre (NHIC), the Advanced Cell Therapy and Research Institute Singapore
(ACTRIS), the Precision Health Research Singapore (PRECISE), and the Singapore
Translational Cancer Consortium (STCC).

Restricted, Non-Sensitive